Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Sep 5, 2007

Thermo Fisher Scientific Picks Up Instrument Sales Business of Davis Inotek

  • Thermo Fisher Scientific acquired the instrument sales segment of Davis Inotek Instruments. The business will be branded Davis Instruments. It will include test, measurement, and process control tools but will exclude related calibration services.

    Davis Inotek’s instrument sales arm had revenues of approximately $30 million in 2006, according to Thermo Fisher Scientific. It will become a part of the Cole-Parmer customer channel, which provides technical instruments, equipment, and supplies to industrial, pharmaceutical, academic, and government customers.

    “The addition of Davis Instruments is a perfect complement to the Cole-Parmer channel, and will strengthen our ability to meet our customers' needs through a range of convenient purchasing options,” comments Marijn E. Dekkers, president and CEO of Thermo Fisher Scientific.



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »